Cofoe Medical Technology Co.,Ltd. (SHE:301087)
33.52
-0.17 (-0.50%)
At close: May 14, 2025, 2:57 PM CST
Cofoe Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
Net Income | 264.24 | 254.28 | 301.68 | 428.86 | 423.95 | 123.69 | Upgrade
|
Depreciation & Amortization | 135.47 | 135.47 | 99.67 | 65.28 | 16.44 | 6.58 | Upgrade
|
Other Amortization | 23.35 | 23.35 | 25.21 | 19.06 | 13.44 | 8.13 | Upgrade
|
Loss (Gain) From Sale of Assets | -4.59 | -4.59 | -6.47 | -0.14 | -0.22 | -0.02 | Upgrade
|
Asset Writedown & Restructuring Costs | 2.24 | 2.24 | 35.29 | 0.05 | 27.58 | 4.76 | Upgrade
|
Loss (Gain) From Sale of Investments | -46.3 | -46.3 | -61.31 | -6.02 | 1.43 | -0.22 | Upgrade
|
Provision & Write-off of Bad Debts | -0.59 | -0.59 | 14.37 | 10.78 | - | - | Upgrade
|
Other Operating Activities | 116.16 | 60.12 | 49.71 | 25.28 | 9.58 | 5.61 | Upgrade
|
Change in Accounts Receivable | 140.46 | 140.46 | -441.79 | -263.09 | 44.94 | -136.79 | Upgrade
|
Change in Inventory | -155.96 | -155.96 | -76.73 | -61.89 | -107.83 | -109.28 | Upgrade
|
Change in Accounts Payable | -8.54 | -8.54 | 137.53 | 26.48 | 68.34 | 150.18 | Upgrade
|
Change in Other Net Operating Assets | -1.81 | -1.81 | 27.63 | -3.7 | - | - | Upgrade
|
Operating Cash Flow | 459.82 | 393.82 | 98.91 | 239.99 | 495.77 | 57.4 | Upgrade
|
Operating Cash Flow Growth | 9.81% | 298.16% | -58.78% | -51.59% | 763.74% | 828.91% | Upgrade
|
Capital Expenditures | -217.83 | -373.22 | -639.79 | -513.24 | -373.57 | -105.41 | Upgrade
|
Sale of Property, Plant & Equipment | 0.24 | 1.21 | 1.25 | 0.04 | 0.39 | 0.07 | Upgrade
|
Cash Acquisitions | -55.49 | -12.49 | -243.8 | -37.88 | -7.97 | - | Upgrade
|
Divestitures | 19.51 | 19.51 | - | - | - | - | Upgrade
|
Investment in Securities | 315.35 | 265.75 | 281.99 | -1,529 | -27.01 | 5 | Upgrade
|
Other Investing Activities | 66.57 | 53.57 | 63.26 | 0.05 | - | 0.3 | Upgrade
|
Investing Cash Flow | 128.36 | -45.67 | -537.09 | -2,080 | -408.16 | -100.05 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 335 | 112.7 | Upgrade
|
Long-Term Debt Issued | - | 543.08 | 611.98 | 141.73 | - | - | Upgrade
|
Total Debt Issued | 574.56 | 543.08 | 611.98 | 141.73 | 335 | 112.7 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -94.7 | -137.23 | Upgrade
|
Long-Term Debt Repaid | - | -426 | -442.98 | -409.06 | - | - | Upgrade
|
Total Debt Repaid | -387.35 | -426 | -442.98 | -409.06 | -94.7 | -137.23 | Upgrade
|
Net Debt Issued (Repaid) | 187.22 | 117.07 | 169 | -267.33 | 240.3 | -24.53 | Upgrade
|
Issuance of Common Stock | - | 23.35 | 16.34 | 3,540 | - | 192 | Upgrade
|
Repurchase of Common Stock | -157.02 | -156.32 | - | - | - | - | Upgrade
|
Common Dividends Paid | -251.87 | -249.91 | -259.6 | -2.7 | -32.74 | -5.5 | Upgrade
|
Other Financing Activities | 261.94 | -11.85 | -54.72 | -0.57 | - | 0.25 | Upgrade
|
Financing Cash Flow | 40.26 | -277.66 | -128.98 | 3,269 | 207.56 | 162.21 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.26 | 0.18 | 0.24 | -0.03 | -0.1 | 0 | Upgrade
|
Net Cash Flow | 628.71 | 70.67 | -566.92 | 1,429 | 295.07 | 119.57 | Upgrade
|
Free Cash Flow | 242 | 20.6 | -540.87 | -273.25 | 122.2 | -48.02 | Upgrade
|
Free Cash Flow Margin | 8.13% | 0.72% | -18.17% | -12.01% | 5.15% | -3.28% | Upgrade
|
Free Cash Flow Per Share | 1.20 | 0.10 | -2.60 | -1.66 | 0.78 | -0.31 | Upgrade
|
Cash Income Tax Paid | 160.57 | 200.31 | 113.88 | 165.39 | 188.51 | 61.93 | Upgrade
|
Levered Free Cash Flow | 194.7 | -218.22 | -560.38 | -369.44 | -143.34 | -43.73 | Upgrade
|
Unlevered Free Cash Flow | 207.04 | -209.78 | -553.6 | -365.18 | -142.44 | -40.54 | Upgrade
|
Change in Net Working Capital | -128.89 | 125.02 | 223.35 | 199.48 | 92.27 | 30.15 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.